Cargando…
HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block
Pharmacologic inhibition of LSD1 induces molecular and morphologic differentiation of blast cells in acute myeloid leukemia (AML) patients harboring MLL gene translocations. In addition to its demethylase activity, LSD1 has a critical scaffolding function at genomic sites occupied by the SNAG domain...
Autores principales: | Maiques-Diaz, Alba, Nicosia, Luciano, Basma, Naseer J., Romero-Camarero, Isabel, Camera, Francesco, Spencer, Gary J., Amaral, Fabio M. R., Simeoni, Fabrizio, Wingelhofer, Bettina, Williamson, Andrew J. K., Pierce, Andrew, Whetton, Anthony D., Somervaille, Tim C. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613766/ https://www.ncbi.nlm.nih.gov/pubmed/36171271 http://dx.doi.org/10.1038/s41388-022-02471-y |
Ejemplares similares
-
LSD1 inhibitors disrupt the GFI1 transcription repressor complex
por: Maiques-Diaz, Alba, et al.
Publicado: (2018) -
Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia
por: Maiques-Diaz, Alba, et al.
Publicado: (2018) -
LSD1: biologic roles and therapeutic targeting
por: Maiques-Diaz, Alba, et al.
Publicado: (2016) -
Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia
por: Deb, Gauri, et al.
Publicado: (2019) -
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
por: Lee, Catherine, et al.
Publicado: (2019)